Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 61 for “"target validation"”.

  1. Target Validation For Neurofibromatosis Type 2 Therapeutics.

    … presents two independent potential therapeutic targets. The disease is caused by mutations in the NF2 gene that encodes a tumor suppressor called merlin. Loss of merlin function is associated with increased activity of Rac and p21-activated kinases (PAK) and deregulation of cytoskeletal …

    ucf Repository record for Target Validation For Neurofibromatosis Type 2 Therapeutics. (opens in a new tab)

  2. Generation of new GPCR-antibodies for target validation in tumor diagnosis and therapy

    … receptors (GPCRs) overexpressed on tumors as targets for contrast agent- or radioisotope- labelled ligands. To validate new GPCR targets, new antibodies were needed to investigate expression of GPCRs in normal and cancerous human tissue of the gastrointestinal tract. To investigate the …

    fu-berlin Repository record for Generation of new GPCR-antibodies for target validation in tumor diagnosis and therapy (opens in a new tab)

  3. Target validation of a myokinin receptor from the southern cattle tick Boophilus microplus (Canestrini)

    … that this myokinin receptor might be a suitable target for development of a novel acaricide, this target was validated by immunological disruption. A mixture of peptides, corresponding to the sequence of the extracellular loops of this receptor which were synthesized and linked to a carrier …

    tamu Repository record for Target validation of a myokinin receptor from the southern cattle tick Boophilus microplus (Canestrini) (opens in a new tab)

  4. Expression Analysis and Target Validation of Genes Encoding Cement Proteins in Amblyomma americanum Tick Saliva

    … could lead to the discovery of important targets for development of methods against tick feeding and transmission of disease agents. One of the lines of research in the lab is to understand tick cement formation and deposition through discovery of the protein composition of the tick cement …

    tamu Repository record for Expression Analysis and Target Validation of Genes Encoding Cement Proteins in Amblyomma americanum Tick Saliva (opens in a new tab)

  5. Development of high throughput microfluidic gut-on-a-chip models for drug discovery and target validation in inflammatory bowel disease

    … drug discovery activities in IBD, both at the target validation and compound testing levels. Our results set the ground to improved, more relevant models of the human intestine, in order to better understand this complex pathology, which could in turn lead to the discovery of more efficient and …

    whiterose Download PDF for Development of high throughput microfluidic gut-on-a-chip models for drug discovery and target validation in inflammatory bowel disease (opens in a new tab)

  6. Mutate & conjugate: a method for rapid in-cell validation of epigenetic targets

    <p>A bottleneck in the drug discovery process is target validation. Target validation is the process of demonstrating that engagement with a cellular target is linked to the desired therapeutic effect, confirming that the target has a key role in the disease phenotype. Incomplete or incorrect …

    oxford Repository record for Mutate & conjugate: a method for rapid in-cell validation of epigenetic targets (opens in a new tab)

  7. A bump and hole approach to the development of selective degrons

    … degron system that could be reliably used for target validation. To achieve this, we employed ‘bump and hole’ methodology to identify a ligand that selectively induces degradation of a mutant degron but not the wild type (WT) ZF. Traditional IMiDs, such as thalidomide, lenalidomide and …

    oxford Repository record for A bump and hole approach to the development of selective degrons (opens in a new tab)

  8. Part 1: Isolation of Orexin Receptor Regulators via a Microarray-Based,Two-Color Cell Binding Screen. Part II: Targeted Inactivation of Proteins triggered by Visible Light.

    … (EC50 = 120 nM) of the orexin receptor. Part II. Targeted Inactivation of Proteins Triggered by Visible Light Advances in genomics and proteomics have helped to provide thousands of potential drug targets and thus target validation strategies are more important than ever. Among target validation …

    utswmed Repository record for Part 1: Isolation of Orexin Receptor Regulators via a Microarray-Based,Two-Color Cell Binding Screen. Part II: Targeted Inactivation of Proteins triggered by Visible Light. (opens in a new tab)

  9. Cellular target engagement and selectivity profiling of small molecules for mechanism-of-action studies

    … specific, potent, and selective against off-target interactions, in order to enable target validation. By contrast, low-quality compounds, which display properties of promiscuity, reactivity and instability can in turn be misleading: such compounds, referred to as Pan-Assay Interference …

    oxford Repository record for Cellular target engagement and selectivity profiling of small molecules for mechanism-of-action studies (opens in a new tab)

  10. DEVELOPMENT OF E2 ENZYME MODULATORS USING PHAGE DISPLAYED UBIQUITIN VARIANTS

    Therapeutic advancements in targeting the ubiquitin (Ub) system for cancer treatment are currently on the rise. This system can be perturbed in a variety of ways, which include targeting the enzymes that add Ub to proteins, the enzymes that remove Ub from proteins, and components that recycle …

    toronto-retro Repository record for DEVELOPMENT OF E2 ENZYME MODULATORS USING PHAGE DISPLAYED UBIQUITIN VARIANTS (opens in a new tab)

  11. CELL-BASED PROTEOME PROFILING OF BIOACTIVE COMPOUNDS: EXPANSION AND NEW CONCEPTS

    … have been widely applied in drug discovery and target validation of bioactive compounds. In the first project, different bioorthogonal tags were introduced to lipid precursor, which upon metabolic incorporation allow for lipid imaging. In the second project, photo affinity-based proteome …

    nus Repository record for CELL-BASED PROTEOME PROFILING OF BIOACTIVE COMPOUNDS: EXPANSION AND NEW CONCEPTS (opens in a new tab) Download file for CELL-BASED PROTEOME PROFILING OF BIOACTIVE COMPOUNDS: EXPANSION AND NEW CONCEPTS (opens in a new tab)

  12. Designing a synthetic tumour suppressor protein

    One of the relatively new techniques for target validation is the use of protein aptamers that bind to the target protein. Protein aptamers are small, synthetic, recognition molecules that consist of bioactive binding peptides that are constrained within a stable, compact and biologically inert …

    nus Repository record for Designing a synthetic tumour suppressor protein (opens in a new tab) Download file for Designing a synthetic tumour suppressor protein (opens in a new tab)

  13. Establishing Caenorhabditis elegans as a Platform for Bioaccumulation and Selectivity Screening of Anthelmintic Compounds

    … against C. elegans and bioaccumulation. Second, target validation using a C. elegans prk-1; prk-2 double mutant demonstrated that while VB4182 induces spastic paralysis in wild-type nematodes, the kinase-deficient lines exhibit complete phenotypic resistance. Notably, these mutants displayed a …

    wustl Repository record for Establishing Caenorhabditis elegans as a Platform for Bioaccumulation and Selectivity Screening of Anthelmintic Compounds (opens in a new tab)

  14. Biological applications of novel fluorescent nanoprobes

    … of bioconjugated quantum dots in molecular targeting and imaging of cancer cell markers. Finally, we engineered a novel nanoparticle construct, an activatable quantum probe that activates in the presence of proteolytic activity as a potential method for early cancer detection based on …

    rice Repository record for Biological applications of novel fluorescent nanoprobes (opens in a new tab)

  15. Investigating and exploiting best practices in hit identification and hit to lead chemistry

    … (FBDD) effort was carried out against the enzyme target BCATm. This resulted in elucidation of novel binding interactions against the enzyme. Several series of inhibitors were identified, these are the first known small molecule inhibitors of this enzyme. The compounds identified contained several …

    strathclyde Repository record for Investigating and exploiting best practices in hit identification and hit to lead chemistry (opens in a new tab)

  16. Exploring Novel Chemical Space: From Small Molecules to Cyclic Peptides

    … of potent chemical probes for epigenetic protein targets. Target validation studies, which include optimizing expression, purification and crystallization of several proteins, as well as the development and screening of a small library of small molecules produced by members of the Yudin group are …

    toronto-retro Repository record for Exploring Novel Chemical Space: From Small Molecules to Cyclic Peptides (opens in a new tab)

  17. A BIOMIMETIC MICROFLUIDIC DEVICE FOR MODELING THE LEUKOCYTE ADHESION/MIGRATION CASCADE

    There is a clear need for testing targeted drug carrier systems in a more realistic microenvironment where both biochemical interactions and shear forces are present. This is critical both for understanding of the molecular mechanisms involved in this process and during the drug discovery process. …

    temple Repository record for A BIOMIMETIC MICROFLUIDIC DEVICE FOR MODELING THE LEUKOCYTE ADHESION/MIGRATION CASCADE (opens in a new tab)

  18. Targeting Selective Receptor Tyrosine Kinases in Refractory Embryonal Tumors of Childhood

    … (RTKs) have become attractive therapeutic targets and the use of small molecule kinase inhibitors to block their signal transduction functions has led to the discovery of a number of novel therapeutics agents. This research presents the relevant background information on two pediatric …

    calgary Repository record for Targeting Selective Receptor Tyrosine Kinases in Refractory Embryonal Tumors of Childhood (opens in a new tab)

Page 1 of 4